News

Better understanding of the vaginal microbiome may provide new insights into HIV acquisition.

At CROI 2018, the World Health Organization released updated guidelines for cryptococcal disease in HIV-infected adults.

For use as donor screening tests on samples from individual human donors, the tests will identify antibodies to Babesia microti in human plasma samples and B. microti DNA in human whole blood samples.

Study results revealed that dolutegravir appears to be effective and well-tolerated in HIV/tuberculosis (TB) co-infected adults also receiving rifampin-based TB therapy.

First detailed analysis by race and risk group finds that two-thirds of those who could benefit from PrEP are African American or Latino, but they account for the smallest percentage of prescriptions to date.

Week 48 safety results show that switching to B/F/TAF was noninferior to remaining on DTG/ABC/3TC.

Better understanding of the pathogenesis of tuberculosis can help inform the development of a new, effective vaccine.

The World Health Organization reports that declining vaccination rates caused a 4-fold increase in measles cases in Europe last year, which prompted European health ministers to convene a meeting to discuss efforts to eliminate the virus.

Week 24 safety and efficacy data on women who switched from a baseline regimen (SBR) to B/F/TAF were presented at CROI 2018.

More research is needed but characterizing the biologic risk factors associated with HIV that are specific to transgender women may be key to informing more effective preventive strategies.

Research suggests misperceptions about the risk of HIV infection should be corrected at the time of testing, with PrEP initiated same-day if appropriate.

Although antiretroviral therapy has led to significantly longer life expectancies among individuals with HIV, this, in turn, has contributed to the likelihood that these individuals will develop age-related comorbidities at earlier ages.

International interdisciplinary collaboration will bring us that much closer to a cure for HIV.

In case you missed them, we’ve compiled a list of the latest recalls posted this week.

The US Food and Drug Administration (FDA) has weighed in on the strains to be included in the 2018-2019 influenza vaccine.

In case you missed them, we’ve compiled the top five infectious disease articles from this past week.

An outbreak of Lassa fever in Nigeria that began at the start of the year has now soared to become the country’s biggest outbreak of the virus to date. Nigerian and global health officials are now working together to stop the outbreak.

The first global estimate of tuberculosis (TB) rates among young people find that about 1.8 million individuals in this age group develop the disease each year.

The new test can differentiate between Lyme disease and 7 other tick-borne diseases.

These deadly infections are often treated with combination therapy, but a new study finds no significant difference in outcomes when using a 2-drug regimen versus a single-drug regimen.

Contagion® will be providing exclusive coverage on the conference, and so, keep your eyes peeled for session coverage and interviews with some of the key presenters.

CARB-X, the international partnership between governmental and charitable groups in the United States and the United Kingdom, has announced new funding for the development of new antibiotics to fight drug-resistant bacteria.

The results of the trial revealed that the tablet reduced the rate of infection with influenza by 48%.

The institute has made the development of the vaccine “one of its highest priorities.”

A new bill introduced by a group of senators aims to boost universal flu vaccine research by $1 billion over the next 5 years, as health officials continue to investigate the cause of the flu shot’s low efficacy.

High prescribing continues despite the fact that heavy use of these agents can facilitate the development of multidrug-resistant bacteria and tendon, muscle, joint, and central nervous system damage.

SMUCLA implements high-touch wipe down intervention to address the need for environmental disinfection of cancer patient care areas.

NIAID Vaccine Research Center scientists alters broadly neutralizing HIV antibody to make it last longer in the blood.

Infectious disease physicians often have to fight to garner the attention of policymakers.

Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is associated with high mortality.